How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.
Roderick de Greef, insider at BioLife Solutions

Roderick de Greef Insider Information

Roderick (Rod) de Greef has served as BioLife’s Chief Financial Officer since May of 2016. He was additionally appointed Chief Operating Officer in December 2019. Rod has a longstanding association with BioLife, having served as a director of the company from June 2000 through November 2013 and provided the company with strategic and financial consulting services from July 2007 through August 2011.

Due to his extensive experience in business and corporate finance, Rod is in high demand as an officer and director of public companies. He has served as a director and  chairman of the Audit Committee of the Board of Directors of Indonesia Energy Corporation Limited since February 2019.  Rod has twice served the mobile communications company Pareteum Corporation (2008-2011 and 2015-2017), as a director, Chair of the Audit Committee, and a member of the Nominating and Corporate Governance Committee and the Compensation Committee. Rod was Chairman of the Board at Cambridge Heart, Inc. from November 2008 to October 2013 and went on to serve as President and sole Director of that company’s privately held successor, Cambridge Cardiac Technologies, from November 2013 to October 2014. He served as a director, member of the audit committee and chairman of the compensation committee for Endologix, Inc. from November 2003 to May 2013.  From 2001 to 2006, Rod was Executive Vice President and Chief Financial Officer of NASDAQ-listed Cardiac Science, Inc.

Rod has an MBA from the University of Oregon, and a B.A in Economics and International Relations from San Francisco State University.

What is Roderick de Greef's net worth?

The estimated net worth of Roderick de Greef is at least $1.67 million as of April 18th, 2022. Mr. de Greef owns 129,780 shares of BioLife Solutions stock worth more than $1,668,971 as of May 22nd. This net worth estimate does not reflect any other investments that Mr. de Greef may own. Additionally, Mr. de Greef receives a salary of $390,890.00 as CFO at BioLife Solutions. Learn More about Roderick de Greef's net worth.

How old is Roderick de Greef?

Mr. de Greef is currently 62 years old. There are 6 older executives and no younger executives at BioLife Solutions. Learn More on Roderick de Greef's age.

What is Roderick de Greef's salary?

As the CFO of BioLife Solutions, Inc., Mr. de Greef earned a total compensation package of $3,054,078.00 in 2020. Mr. de Greef earned a salary of $390,889.00, stock awards of $2,663,189.00, and no other miscellaneous compensation. There are 2 executives that earn more than Mr. de Greef. The highest earning executive at BioLife Solutions is Mr. Michael P. Rice, Chairman & CEO, who commands a salary of $514,710.00 per year. Learn More on Roderick de Greef's salary.

How do I contact Roderick de Greef?

The corporate mailing address for Mr. de Greef and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at [email protected] Learn More on Roderick de Greef's contact information.

Has Roderick de Greef been buying or selling shares of BioLife Solutions?

In the last ninety days, Roderick de Greef has sold $559,700.36 of BioLife Solutions stock. 0 shares of BMO Capital Markets stock in a transaction that occurred on Sunday, May 22nd. Learn More on Roderick de Greef's trading history.

Who are BioLife Solutions' active insiders?

BioLife Solutions' insider roster includes Sarah Aebersold (VP), Todd Berard (CMO), Roderick de Greef (CFO), Karen Foster (Insider), Andrew Hinson (Director), Aby Mathew (VP), Michael Rice (CEO), Joseph Schick (Director), Marcus Schulz (CRO), and Troy Wichterman (CFO). Learn More on BioLife Solutions' active insiders.

Are insiders buying or selling shares of BioLife Solutions?

In the last twelve months, insiders at the medical equipment provider sold shares 130 times. They sold a total of 814,217 shares worth more than $30,540,389.39. The most recent insider tranaction occured on May, 13th when CEO Michael Rice sold 165 shares worth more than $2,032.80. Insiders at BioLife Solutions own 5.9 % of the company. Learn More about insider trades at BioLife Solutions.

Information on this page was last updated on 5/13/2022.

Roderick de Greef Insider Trading History at BioLife Solutions

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/18/2022Sell18,530$17.59$325,942.70129,780View SEC Filing Icon  
4/7/2022Sell10,713$21.82$233,757.66104,464View SEC Filing Icon  
1/7/2022Sell10,816$30.75$332,592.00View SEC Filing Icon  
12/29/2021Sell705$39.37$27,755.85View SEC Filing Icon  
11/18/2021Sell7,000$50.75$355,250.00View SEC Filing Icon  
11/16/2021Sell7,000$51.39$359,730.00View SEC Filing Icon  
10/25/2021Sell2,371$44.62$105,794.02View SEC Filing Icon  
10/14/2021Sell1,221$39.97$48,803.37View SEC Filing Icon  
9/28/2021Sell689$43.12$29,709.68View SEC Filing Icon  
8/19/2021Sell12,000$45.12$541,440.00162,853View SEC Filing Icon  
8/17/2021Sell12,000$44.81$537,720.00View SEC Filing Icon  
6/29/2021Sell685$43.75$29,968.75174,853View SEC Filing Icon  
4/15/2021Sell5,000$33.69$168,450.00189,538View SEC Filing Icon  
4/13/2021Sell10,919$35.08$383,038.52189,538View SEC Filing Icon  
4/1/2021Sell3,855$36.53$140,823.15186,171View SEC Filing Icon  
3/26/2021Sell2,893$35.01$101,283.93176,239View SEC Filing Icon  
2/19/2021Sell4,509$40.76$183,786.84161,033View SEC Filing Icon  
2/17/2021Sell4,424$41.55$183,817.20161,033View SEC Filing Icon  
11/16/2020Sell30,000$31.77$953,100.00166,293View SEC Filing Icon  
11/13/2020Sell10,000$31.87$318,700.00166,293View SEC Filing Icon  
9/29/2020Sell1,781$28.63$50,990.0356,293View SEC Filing Icon  
3/5/2020Sell10,000$13.72$137,200.0035,859View SEC Filing Icon  
2/7/2020Sell10,000$13.32$133,200.0035,859View SEC Filing Icon  
2/5/2020Sell10,000$14.06$140,600.0035,859View SEC Filing Icon  
1/7/2020Sell10,000$15.46$154,600.0035,859View SEC Filing Icon  
12/5/2019Sell10,000$16.19$161,900.0035,859View SEC Filing Icon  
11/7/2019Sell10,000$17.08$170,800.0035,859View SEC Filing Icon  
10/4/2019Sell10,000$15.63$156,300.0035,859View SEC Filing Icon  
10/2/2019Sell10,000$15.76$157,600.0035,859View SEC Filing Icon  
9/6/2019Sell10,000$19.88$198,800.0035,859View SEC Filing Icon  
9/4/2019Sell10,000$19.46$194,600.0035,859View SEC Filing Icon  
8/2/2019Sell30,000$18.96$568,800.0035,859View SEC Filing Icon  
7/31/2019Sell10,000$19.17$191,700.0035,859View SEC Filing Icon  
7/3/2019Sell10,000$16.09$160,900.0035,859View SEC Filing Icon  
7/1/2019Sell10,000$17.23$172,300.0035,859View SEC Filing Icon  
6/19/2019Sell10,000$17.60$176,000.0035,859View SEC Filing Icon  
5/23/2019Sell14,500$17.88$259,260.0025,859View SEC Filing Icon  
5/16/2019Sell10,000$16.76$167,600.0040,359View SEC Filing Icon  
4/17/2019Sell10,000$16.53$165,300.0040,359View SEC Filing Icon  
3/20/2019Sell10,000$19.83$198,300.0040,359View SEC Filing Icon  
2/20/2019Sell10,000$17.23$172,300.0024,583View SEC Filing Icon  
1/17/2019Sell10,000$12.49$124,900.0024,583View SEC Filing Icon  
12/19/2018Sell10,000$10.67$106,700.0024,583View SEC Filing Icon  
10/17/2018Sell10,000$12.95$129,500.0024,583View SEC Filing Icon  
9/19/2018Sell10,000$17.22$172,200.0024,583View SEC Filing Icon  
8/16/2018Sell10,000$19.10$191,000.0024,583View SEC Filing Icon  
7/18/2018Sell10,000$20.00$200,000.0024,583View SEC Filing Icon  
5/29/2018Sell15,000$9.65$144,750.0024,583View SEC Filing Icon  
5/25/2018Sell10,000$9.35$93,500.0024,583View SEC Filing Icon  
See Full Table

Roderick de Greef Buying and Selling Activity at BioLife Solutions

This chart shows Greef Roderick De's buying and selling at BioLife Solutions by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioLife Solutions Company Overview

BioLife Solutions logo
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Read More

Today's Range

Now: $12.86
Low: $11.99
High: $12.91

50 Day Range

MA: $17.30
Low: $10.54
High: $24.61

2 Week Range

Now: $12.86
Low: $10.40
High: $60.67

Volume

340,532 shs

Average Volume

572,701 shs

Market Capitalization

$545.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.01
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.